Oncol Rep 39: [Related article:] 491–500, 2018; DOI:
10.3892/or.2017.6142
Following the publication of this paper, it was
drawn to the Editor's attention by a concerned reader that the
control GAPDH western blotting bands shown in Fig. 4H on p. 496
were strikingly similar to data that were submitted for publication
in advance of this article in different form by different authors
at different research institutes [Liu F, Bai C and Guo Z: The
prognostic value of osteopontin in limited-stage small cell lung
cancer patients and its mechanism. Oncotarget 8: 70084-70096,
2017]. A further independent investigation conducted in the
Editorial Office revealed that other western blotting data were
likely to have been shared in common, comparing between the two
articles.
Owing to the fact that the contentious data in the
above article had already been submitted for publication prior to
the submission of this article to Oncology Reports, the
Editor has decided that this paper should be retracted from the
Journal. After having been in contact with the authors, it was
admitted that the authors Feng Chang, Jian-Na Liu and Jun-Xin Lin
did not initially provide their agreement to be authors on this
paper; otherwise, the rest of the authors accepted the decision to
retract the paper. The Editor apologizes to the readership for any
inconvenience caused.
